State Board of Administration of Florida Retirement System increased its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 0.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 82,745 shares of the medical device company’s stock after purchasing an additional 260 shares during the quarter. State Board of Administration of Florida Retirement System owned approximately 0.17% of Cooper Companies, Inc. (The) worth $19,620,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Advisory Services Network LLC increased its position in Cooper Companies, Inc. (The) by 30.6% in the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after buying an additional 107 shares during the period. Schwab Charles Investment Management Inc. increased its position in Cooper Companies, Inc. (The) by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,686 shares of the medical device company’s stock worth $58,583,000 after buying an additional 13,004 shares during the period. Amalgamated Bank increased its position in Cooper Companies, Inc. (The) by 27.0% in the 2nd quarter. Amalgamated Bank now owns 9,764 shares of the medical device company’s stock worth $2,338,000 after buying an additional 2,073 shares during the period. Koch Industries Inc. bought a new position in Cooper Companies, Inc. (The) in the 2nd quarter worth approximately $312,000. Finally, Scout Investments Inc. increased its position in shares of Cooper Companies, Inc. (The) by 29.3% during the second quarter. Scout Investments Inc. now owns 116,320 shares of the medical device company’s stock valued at $27,849,000 after purchasing an additional 26,370 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

In other Cooper Companies, Inc. (The) news, Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/09/state-board-of-administration-of-florida-retirement-system-has-19-62-million-position-in-cooper-companies-inc-the-coo.html.

Shares of Cooper Companies, Inc. (NYSE COO) opened at $230.48 on Thursday. Cooper Companies, Inc. has a 1 year low of $158.73 and a 1 year high of $256.39. The firm has a market capitalization of $11,225.53, a price-to-earnings ratio of 24.53, a price-to-earnings-growth ratio of 1.97 and a beta of 0.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The firm had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same period in the prior year, the business posted $2.30 earnings per share. The business’s revenue was up 8.0% compared to the same quarter last year. equities research analysts anticipate that Cooper Companies, Inc. will post 9.72 EPS for the current fiscal year.

COO has been the topic of a number of research reports. Robert W. Baird restated a “buy” rating and set a $273.00 price objective (up from $267.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 price objective on the stock in a research report on Tuesday, August 29th. Jefferies Group LLC set a $250.00 price objective on Cooper Companies, Inc. (The) and gave the company a “buy” rating in a research report on Thursday, August 17th. Oppenheimer Holdings, Inc. restated a “hold” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Finally, Cleveland Research restated a “buy” rating on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, August 22nd. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $261.11.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.